← News·MarketsMarkets

Eli Lilly lifts 2026 revenue guidance to $87 billion after Zepbound and Mounjaro drive quarterly beat

LLY is in focus after Eli Lilly easily topped quarterly earnings estimates and raised its full-year 2026 revenue outlook, with Zepbound and Mounjaro sales cited as the demand catalyst. The

NM
NewsMV Markets Desk
3 min read
6 August 2026Markets desk
Share this dispatch
TickersLLYUBER
Categoryearnings

Filed via cnbc.com

Keep reading

More from the markets desk